Caption Management’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-25,000
| Closed | -$228K | – | 1994 |
|
|
2025
Q2 | $228K | Hold |
25,000
| – | – | ﹤0.01% | 1242 |
|
|
2025
Q1 | $199K | Buy |
25,000
+16,800
| +205% | +$123K | ﹤0.01% | 1272 |
|
|
2024
Q4 | $44.5K | Hold |
8,200
| – | – | ﹤0.01% | 1374 |
|
|
2024
Q3 | $59.2K | Hold |
8,200
| – | – | ﹤0.01% | 1158 |
|
|
2024
Q2 | $89.1K | Sell |
8,200
-21,800
| -73% | -$279K | ﹤0.01% | 1029 |
|
|
2024
Q1 | $562K | Hold |
30,000
| – | – | 0.01% | 852 |
|
|
2023
Q4 | $650K | Sell |
30,000
-30,000
| -50% | -$595K | 0.01% | 897 |
|
|
2023
Q3 | $1.23M | Buy |
60,000
+30,000
| +100% | +$866K | 0.02% | 715 |
|
|
2023
Q2 | $1.41M | Hold |
30,000
| – | – | 0.03% | 586 |
|
|
2023
Q1 | $1.26M | Buy |
+30,000
| New | +$1.29M | 0.02% | 574 |
|
|
2022
Q2 | – | Sell |
-1,400
| Closed | -$47K | – | 1781 |
|
|
2022
Q1 | $47K | Sell |
1,400
-256,600
| -99% | -$9.65M | ﹤0.01% | 1363 |
|
|
2021
Q4 | $11M | Buy |
258,000
+228,000
| +760% | +$9.55M | 0.12% | 206 |
|
|
2021
Q3 | $1.33M | Buy |
30,000
+2,500
| +9% | +$115K | 0.02% | 929 |
|
|
2021
Q2 | $1.56M | Sell |
27,500
-3,800
| -12% | -$269K | 0.02% | 769 |
|
|
2021
Q1 | $2.34M | Buy |
+31,300
| New | +$2.57M | 0.05% | 470 |
|
|
2020
Q2 | – | Sell |
-20,000
| Closed | -$574K | – | 1157 |
|
|
2020
Q1 | $574K | Sell |
20,000
-37,700
| -65% | -$2.18M | 0.03% | 517 |
|
|
2019
Q4 | $4.16M | Sell |
57,700
-4,800
| -8% | -$590K | 0.14% | 201 |
|
|
2019
Q3 | $8.77M | Buy |
62,500
+32,400
| +108% | +$5.42M | 0.46% | 50 |
|
|
2019
Q2 | $5.51M | Buy |
+30,100
| New | +$5.14M | 0.28% | 102 |
|
|
2019
Q1 | – | Sell |
-20,000
| Closed | -$1.92M | – | 714 |
|
|
2018
Q4 | $1.92M | Buy |
+20,000
| New | +$2.29M | 0.15% | 188 |
|
Other funds holding SAGE
IA
HNB
Caption Management's SAGE Position: Q4 2024 in Review
Caption Management sold out of Sage Therapeutics (SAGE) in Q4 2024, closing a stake of 500 shares — an estimated $3.06K sold.
Caption Management first reported a position in SAGE in Q4 2018 and held it in 13 quarters. The position peaked at $7.93M in Q2 2021. 176 funds tracked by Wall St. Rank hold SAGE as of Q4 2024.
- Caption Management reported no remaining Sage Therapeutics position as of Q4 2024 after selling out during the quarter.
- Caption Management sold 500 Sage Therapeutics shares in Q4 2024, an estimated $3.06K.
- Caption Management first reported a position in Sage Therapeutics in Q4 2018 and held it in 13 quarters.
- Caption Management's Sage Therapeutics position peaked at $7.93M in Q2 2021.
- 176 funds tracked by Wall St. Rank held Sage Therapeutics as of Q4 2024.
Based on Caption Management's 13F filing for Q4 2024, filed 14 Feb 2025.